CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

VarmX begins global phase 3 trial for VMX C001

Phase 3VMX C001Positive
AI Analysis

Summary

VarmX has initiated a global Phase 3 trial for VMX C001, with the first participant enrolled in the EquilibriX S study.

Clinical Trial Data

Phase

3

Importance:6/10
Sentiment:
0.50
Phase 3Clinical TrialVMX C001EquilibriX S
Related Companies

Read the original article

Published by PharmaTimes on August 25, 2026 9:49 AM

Read Original